1. Celebrating the Annals of Surgical Oncology’s 25-Year Anniversary: One of the Most Cited Surgical Journals in the World

   • Charles M. Balch
   • Mark Roh
   • Deborah Whippen

   Health Services Research and Global Oncology 06 December 2017 Pages: 1 - 4

   

2. The Annals of Surgical Oncology: An Oncology Journal for Surgeons

   • Charles M. Balch
   • Mark S. Roh
   • Colleen M. Hubona

   Health Services Research and Global Oncology 30 November 2017 Pages: 5 - 6

3. What Is a Surgical Oncologist?

   • Charles Balch

   Health Services Research and Global Oncology 29 November 2017 Pages: 7 - 9

4. The Eighth Edition of TNM: Implications for the Surgical Oncologist

   • David R. Byrd
   • Frederick L. Greene

   Health Services Research and Global Oncology 07 August 2017 Pages: 10 - 12

   

5. Adjacent, Adherent, Invaded: A Spectrum of Biologic Aggressiveness Rather Than a Rationale for Selecting Organ Resection in Surgery of Primary Retroperitoneal Sarcomas

   • Dirk C. Strauss
   • Salvatore L. Renne
   • Alessandro Gronchi

   Bone and Soft Tissue Sarcomas 27 October 2017 Pages: 13 - 16

   

6. Four-Dimensional Computed Tomography: Clinical Impact for Patients with Primary Hyperparathyroidism

   • Nancy Perrier

   Head and Neck Oncology 09 November 2017 Pages: 17 - 17

7. Intraoperative Margin Management in Breast-Conserving Surgery: A Systematic Review of the Literature

   • Richard J. Gray
   • Barbara A. Pockaj
   • Sarah Blair

   Breast Oncology 05 January 2017 Pages: 18 - 27

   

8. Axillary Lymphadenectomy in Sentinel Lymph Node-Positive Breast Cancer

   • Liling Zhu
   • Kai Chen
   • Rebecca Aft

   Breast Oncology 31 March 2017 Pages: 28 - 31

9. Timing of Surgical Resection for Curative Colorectal Cancer with Liver Metastasis

   • Shahzad M. Ali
   • Timothy M. Pawlik
   • David W. Larson

   Colorectal Cancer 21 February 2017 Pages: 32 - 37

   

10. Impact of Proximal Vascular Ligation on Survival of Patients with Colon Cancer

    • Ian M. Paquette
    • Robert D. Madoff
    • George J. Chang

    Gastrointestinal Oncology 09 December 2016 Pages: 38 - 45

11. Role of Radical Antegrade Modular Pancreatosplenectomy (RAMPS) and Pancreatic Cancer

    • Yun Shin Chun

    Pancreatic Tumors 15 November 2016 Pages: 46 - 50

    

12. The Role of Venous and Arterial Resection in Pancreatic Cancer Surgery

    • Gyulnara G. Kasumova
    • W. Charles Conway
    • Jennifer F. Tseng

    Pancreatic Tumors 23 November 2016 Pages: 51 - 58

13. Role of Segmentectomy in Treatment of Early-Stage Non–Small Cell Lung Cancer

    • Mark Hennon
    • Rodney J. Landreneau

    Thoracic Oncology 01 March 2017 Pages: 59 - 63

14. Minimally Invasive and Open Approaches to Mediastinal Nodal Assessment

    • Crystal J. Erickson
    • Felix G. Fernandez
    • Rishindra M. Reddy

    Thoracic Oncology 05 January 2017 Pages: 64 - 67

15. When Should Negative Endobronchial Ultrasonography Findings be Confirmed by a More Invasive Procedure?

    • Basil S. Nasir
    • Kazuhiro Yasufuku
    • Moishe Liberman

    Thoracic Oncology 10 January 2017 Pages: 68 - 75

    

16. Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei

    • Haroon A. Choudry
    • Reetesh K. Pai
    • David L. Bartlett

    Colorectal Cancer 06 November 2017 Pages: 76 - 82

    

17. Surgical Resection Does Not Improve Survival in Multifocal Intrahepatic Cholangiocarcinoma: A Comparison of Surgical Resection with Intra-Arterial Therapies

    • G. Paul Wright
    • Samantha Perkins
    • James F. Pingpank Jr.

    Hepatobiliary Tumors 23 October 2017 Pages: 83 - 90

    

18. Factors Associated with 60-Day Readmission Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

    • Kaitlyn J. Kelly
    • Luis Cajas
    • Andrew M. Lowy

    Gastrointestinal Oncology 31 October 2017 Pages: 91 - 97

    

19. Surgical Management of Primary Retroperitoneal Sarcomas: Rationale for Selective Organ Resection

    • Mark Fairweather
    • Jiping Wang
    • Chandrajit P. Raut

    Bone and Soft Tissue Sarcomas 24 October 2017 Pages: 98 - 106

    

20. Long-Term Survival According to Histology and Radiologic Response to Preoperative Chemotherapy in 126 Patients Undergoing Resection of Non-GIST Sarcoma Liver Metastases

    • Claire Goumard
    • Leonardo P. Marcal
    • Claudius Conrad

    Bone and Soft Tissue Sarcomas 07 November 2017 Pages: 107 - 116

    

21. Four-Dimensional Computed Tomography: Clinical Impact for Patients with Primary Hyperparathyroidism

    • Yuan Tian
    • Sharman Tan Tanny
    • Julie A. Miller

    Endocrine Tumors 23 October 2017 Pages: 117 - 121

    

22. Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis

    • Apostolos Gaitanidis
    • Dhaval Patel
    • Electron Kebebew

    Endocrine Tumors 13 November 2017 Pages: 122 - 130

    

23. Radioactive Seed Localization Versus Wire Localization for Nonpalpable Breast Lesions: A Two-Year Initial Experience at a Large Community Hospital

    • Lacey Stelle
    • Taylor Schoenheit
    • Anna Higham

    Breast Oncology 13 November 2017 Pages: 131 - 136

    

24. Meta-Analysis of Local Invasive Breast Cancer Recurrence After Electron Intraoperative Radiotherapy

    • Jay K. Harness
    • Kalatu Davies
    • Frank Vicini

    Breast Oncology 06 November 2017 Pages: 137 - 147

    

25. Pre-operative Axillary Ultrasound-Guided Needle Sampling in Breast Cancer: Comparing the Sensitivity of Fine Needle Aspiration Cytology and Core Needle Biopsy

    • Ashley R. Topps
    • Simon P. Barr
    • Anthony J. Maxwell

    Breast Oncology 23 October 2017 Pages: 148 - 153

26. Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy

    • James Laird
    • Benjamin Lok
    • Lior Z. Braunstein

    Breast Oncology 01 November 2017 Pages: 154 - 163

    

27. The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy

    • Olga Kantor
    • Gaurav Ajmani
    • Katharine Yao

    Breast Oncology 10 November 2017 Pages: 164 - 172

    

28. Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy

    • Dai Shida
    • Shunsuke Tsukamoto
    • Yukihide Kanemitsu

    Colorectal Cancer 23 October 2017 Pages: 173 - 178

    

29. Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?

    • Guillaume Passot
    • Bradford J. Kim
    • on behalf of the BIG-RENAPE Working Group

    Colorectal Cancer 25 October 2017 Pages: 179 - 187

    

30. The Relationship Between Clavien–Dindo Morbidity Classification and Oncologic Outcomes After Colorectal Cancer Resection

    • Leonardo C. Duraes
    • Luca Stocchi
    • Conor P. Delaney

    Colorectal Cancer 07 November 2017 Pages: 188 - 196

    

31. Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response?

    • Britt J. P. Hupkens
    • Monique Maas
    • Geerard L. Beets

    Colorectal Cancer 13 November 2017 Pages: 197 - 203

    

32. Prognostic Impact of Tumor-Budding Grade in Stages 1–3 Colon Cancer: A Retrospective Cohort Study

    • Bo Young Oh
    • Yoon Ah Park
    • Yong Beom Cho

    Colorectal Cancer 30 October 2017 Pages: 204 - 211

    

33. Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases

    • Charlotte E. L. Klaver
    • Nadine C. M. van Huijgevoort
    • André D’Hoore

    Colorectal Cancer Open access 26 October 2017 Pages: 212 - 220

    

34. Induced Bias Due to Crossover Within Randomized Controlled Trials in Surgical Oncology: A Meta-regression Analysis of Minimally Invasive versus Open Surgery for the Treatment of Gastrointestinal Cancer

    • George Garas
    • Sheraz R. Markar
    • Thanos Athanasiou

    Gastrointestinal Oncology Open access 06 November 2017 Pages: 221 - 230

    

35. Vitamin Status and the Development of Postoperative Cognitive Decline in Elderly Surgical Oncologic Patients

    • Linda B. M. Weerink
    • Barbara L. van Leeuwen
    • Geertruida H. de Bock

    Gastrointestinal Oncology Open access 20 October 2017 Pages: 231 - 238

    

36. Prophylactic Cholecystectomy at Time of Surgery for Small Bowel Neuroendocrine Tumor Does Not Increase Postoperative Morbidity

    • Andrew J. Sinnamon
    • Madalyn G. Neuwirth
    • Giorgos C. Karakousis

    Gastrointestinal Oncology 24 October 2017 Pages: 239 - 245

    

37. Reduced Port Laparoscopic Distal Gastrectomy with D2 Lymphadenectomy

    • Tian Lin
    • Ting-yu Mou
    • Guo-xin Li

    Gastrointestinal Oncology 24 October 2017 Pages: 246 - 246

38. Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety

    • Marco Petrillo
    • Camilla Nero
    • Anna Fagotti

    Gynecologic Oncology 13 November 2017 Pages: 247 - 254

    

39. Adjuvant Chemoradiotherapy is Associated with Improved Survival for Patients with Resected Gallbladder Carcinoma: A Systematic Review and Meta-analysis

    • Byoung Hyuck Kim
    • Jeanny Kwon
    • Joseph M. Herman

    Hepatobiliary Tumors 27 October 2017 Pages: 255 - 264

    

40. Wait Times for Melanoma Surgery: Is There an Association with Overall Survival?

    • Alyson B. Crawford
    • Carolyn Nessim
    • Carl van Walraven

    Melanomas 03 November 2017 Pages: 265 - 270

    

41. Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study

    • Carlo Riccardo Rossi
    • Simone Mocellin
    • on behalf of the Italian Melanoma Intergroup (IMI)

    Melanomas 24 October 2017 Pages: 271 - 279

    

42. Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective

    • John F. Ryan
    • Vincent P. Groot
    • Joseph M. Herman

    Pancreatic Tumors 23 October 2017 Pages: 280 - 289

    

43. Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease

    • Alexandra G. Lopez-Aguiar
    • Cecilia G. Ethun
    • Kenneth Cardona

    Pancreatic Tumors 27 October 2017 Pages: 290 - 298

    

44. Effect of Plasma-Activated Lactated Ringer’s Solution on Pancreatic Cancer Cells In Vitro and In Vivo

    • Yusuke Sato
    • Suguru Yamada
    • Yasuhiro Kodera

    Pancreatic Tumors 14 November 2017 Pages: 299 - 307

    

45. Impact of Sarcopenic Obesity on Failure to Rescue from Major Complications Following Pancreaticoduodenectomy for Cancer: Results from a Multicenter Study

    • Nicolò Pecorelli
    • Giovanni Capretti
    • Marco Braga

    Pancreatic Tumors 07 November 2017 Pages: 308 - 317

    

46. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk

    • Andrew D. Newton
    • Jarrod D. Predina
    • Sunil Singhal

    Thoracic Oncology 16 November 2017 Pages: 318 - 325

    

47. Short-Term Outcomes Following Minimally Invasive and Open Esophagectomy: A Population-Based Study from Finland and Sweden

    • Joonas H. Kauppila
    • Olli Helminen
    • Eero Sihvo

    Gastrointestinal Oncology 01 November 2017 Pages: 326 - 332

    

48. Cervicothoracoscopic Approach in Esophagectomy

    • Akihiko Okamura
    • Masayuki Watanabe
    • Shinji Mine

    Thoracic Oncology 30 October 2017 Pages: 333 - 333

49. Impact of County Rurality and Urologist Density on the Practice of Inguinal Lymph Node Dissection and Mortality in Patients Diagnosed with Squamous Cell Carcinoma of the Penis

    • Michael Romanelli
    • Tariq Issa
    • Shaheen Alanee

    Urologic Oncology 06 November 2017 Pages: 334 - 341

    

50. Prognostic and Predictive Value of O⁶-methylguanine Methyltransferase for Chemotherapy in Patients with Muscle-Invasive Bladder Cancer

    • Junyu Zhang
    • Yu Zhu
    • Bo Dai

    Urologic Oncology 07 November 2017 Pages: 342 - 348